Actively Recruiting
Behavioral Activation for the Prevention and Treatment of Depression in Older Adults in a Municipal Context: a Randomized Controlled Trial
Led by Sormland County Council, Sweden · Updated on 2024-12-16
160
Participants Needed
1
Research Sites
34 weeks
Total Duration
On this page
Sponsors
S
Sormland County Council, Sweden
Lead Sponsor
E
Eskilstuna municipality
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating a brief psychological treatment called Behavioral Activation (BA) to prevent and treat depression in adults aged 65 and older within a municipal care setting in Sweden. Depression is common among older adults and affects quality of life and daily functioning. This trial aims to understand whether BA can improve depressive and anxiety symptoms, self-rated activation, functional ability, loneliness, self-efficacy, mental wellbeing, quality of life, and reduce the need for community care services. The study also explores experiences of both patients and therapists involved in the BA treatment. Participants will continue their usual care, and half will be randomly assigned to receive a five-session BA treatment over two months, delivered face-to-face in their homes by social workers. The BA sessions start weekly for four weeks, followed by a booster session four weeks later. The other half will receive care as usual without the BA intervention. This design allows comparison between BA plus usual care and usual care alone. Participants will complete questionnaires at the start, after two months, and at 3, 6, and 12 months to assess outcomes including depressive symptoms measured with the Montgomery-Åsberg Depression Rating Scale. Additional evaluations include anxiety, disability, loneliness, self-efficacy, mental wellbeing, quality of life, and community care needs. The total participation spans one year, with data collected to understand both short- and long-term effects of the BA treatment.
CONDITIONS
Brief Title
Behavioral Activation for the Prevention and Treatment of Depression in Older Adults in a Municipal Context
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 65 years or older
- Score of 5 points or above on the Geriatric Depression Scale 15 (GDS-15)
- Fluent in written and spoken Swedish
- Consents to participate in the trial
You will not qualify if you...
- Unable to use patient materials due to visual impairment
- Unable to communicate with therapist due to hearing impairment
- Diagnosis of major neurocognitive disorder
- Score below 25 points on the Mini Mental State Examination (MMSE)
- Elevated suicide risk
- Current substance or alcohol use disorder
- Previous or current psychotic disorder
- Previous or current bipolar disorder
- Ongoing psychological treatment or psychotherapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Approximately 2 months
Participants randomized to the intervention receive a five-session brief behavioral activation treatment delivered face-to-face in their home over two months, as an add-on to their usual care. Sessions 1 to 4 occur weekly, and session 5 is a booster session four weeks after session 4.
5 visits (in-person) in participant's home over 2 months, with sessions 1-4 weekly and session 5 four weeks after session 4
Duration - Ongoing during study period
Participants randomized to usual care continue their care as usual provided by primary care and/or municipal care without additional intervention.
Duration - 12 months post-intervention
All participants complete questionnaires at baseline, 2 months, and at 3, 6, and 12 months post intervention or equivalent timepoints to assess depressive symptoms and other outcomes.
5 questionnaire assessments: baseline, 2 months, 3, 6, and 12 months post intervention or equivalent
Trial Site Locations
Total: 1 location
1
Eskilstuna kommun
Eskilstuna, Sörmland, Sweden
Actively Recruiting
Research Team
J
Johnny Pellas, PhD
M
Marina Arkkukangas, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here